| scholarly article | Q13442814 |
| P2093 | author name string | Valerie B O'Leary | |
| Saak V Ovsepian | |||
| Inga Antyborzec | |||
| James O Dolly | |||
| P2860 | cites work | Three-dimensional structures of avidin and the avidin-biotin complex | Q24562803 |
| Structural origins of high-affinity biotin binding to streptavidin | Q27728497 | ||
| Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics | Q28141424 | ||
| The cholinergic hypothesis of geriatric memory dysfunction | Q28277644 | ||
| Selective in vivo fluorescence labelling of cholinergic neurons containing p75(NTR) in the rat basal forebrain | Q28577915 | ||
| Laser scanning and electron microscopic evidence for rapid and specific in vivo labelling of cholinergic neurons in the rat basal forebrain with fluorochromated antibodies | Q30874993 | ||
| On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis | Q33421837 | ||
| The basal forebrain corticopetal system revisited | Q33692809 | ||
| A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. | Q33711477 | ||
| Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors | Q34028579 | ||
| Local synaptic connections of basal forebrain neurons | Q34041821 | ||
| Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases | Q34092603 | ||
| Neurotrophic factor therapy--prospects and problems | Q34270998 | ||
| The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease | Q34412007 | ||
| Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease | Q34490776 | ||
| Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis | Q34717505 | ||
| Viral vectors for gene delivery to the nervous system | Q35120134 | ||
| Gene therapy for the nervous system: challenges and new strategies | Q35340196 | ||
| The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? | Q35640772 | ||
| The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor | Q35884401 | ||
| Bcl-xL protects adult septal cholinergic neurons from axotomized cell death | Q35931272 | ||
| Adult mouse basal forebrain harbors two distinct cholinergic populations defined by their electrophysiology | Q35942493 | ||
| Intrinsic voltage dynamics govern the diversity of spontaneous firing profiles in basal forebrain noncholinergic neurons | Q36115961 | ||
| Neurotrophin receptor p75 mediates the uptake of the amyloid beta (Aβ) peptide, guiding it to lysosomes for degradation in basal forebrain cholinergic neurons. | Q36362330 | ||
| Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus | Q36387898 | ||
| An update on pharmacological approaches to neurodegenerative diseases | Q36677402 | ||
| Nerve growth factor gene delivery: animal models to clinical trials | Q36827338 | ||
| TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons | Q37260480 | ||
| Cholinergic system during the progression of Alzheimer's disease: therapeutic implications | Q37318152 | ||
| Avidin-biotin technology in targeted therapy | Q37710089 | ||
| Viral vectors for gene delivery to the central nervous system | Q37946113 | ||
| Recent preclinical evidence advancing cell therapy for Alzheimer's disease. | Q38024220 | ||
| A review on cholinesterase inhibitors for Alzheimer's disease | Q38084168 | ||
| Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome | Q38222973 | ||
| Cholinergic system dysfunction and neurodegenerative diseases: cause or effect? | Q38250406 | ||
| Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease | Q38314993 | ||
| Enhanced Synaptic Inhibition Disrupts the Efferent Code of Cerebellar Purkinje Neurons in Leaner Cav2.1 Ca2+ Channel Mutant Mice | Q39871609 | ||
| Basal ganglia lesions after MPTP administration in rhesus monkeys | Q40269198 | ||
| Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors | Q40657761 | ||
| Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission. | Q40909041 | ||
| Gene transfer to the mammalian brain using neural stem cells: a focus on trophic factors, neuroregeneration, and cholinergic neuron systems | Q41000189 | ||
| Internalization and retrograde axonal trafficking of tetanus toxin in motor neurons and trans-synaptic propagation at central synapses exceed those of its C-terminal-binding fragments. | Q42170081 | ||
| Improved lentiviral transduction of ALS motoneurons in vivo via dual targeting | Q42267072 | ||
| Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons | Q42435326 | ||
| Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor | Q42464077 | ||
| 192IgG-saporin immunotoxin-induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei | Q42478713 | ||
| Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons | Q42478941 | ||
| Discharge properties of juxtacellularly labeled and immunohistochemically identified cholinergic basal forebrain neurons recorded in association with the electroencephalogram in anesthetized rats. | Q42483292 | ||
| Cholinergic medial septum neurons do not degenerate in aged 129/Sv control or p75(NGFR)-/-mice | Q42487547 | ||
| EEG correlation of the discharge properties of identified neurons in the basal forebrain | Q42493111 | ||
| Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease | Q42494887 | ||
| Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor | Q42498523 | ||
| Distribution of [125I]nerve growth factor in the rat brain following a single intraventricular injection: correlation with the topographical distribution of trkA messenger RNA-expressing cells | Q42505941 | ||
| Selective immunolesions of cholinergic neurons in mice: effects on neuroanatomy, neurochemistry, and behavior. | Q42510981 | ||
| Differential oscillatory properties of cholinergic and noncholinergic nucleus basalis neurons in guinea pig brain slice | Q42520118 | ||
| Effects of intraventricular transplantation of NGF-secreting cells on cholinergic basal forebrain neurons after partial immunolesion | Q42523376 | ||
| Survival of cholinergic forebrain neurons in developing p75NGFR-deficient mice | Q42527534 | ||
| Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway | Q42600951 | ||
| Analysis of retrograde transport in motor neurons reveals common endocytic carriers for tetanus toxin and neurotrophin receptor p75NTR. | Q42951910 | ||
| CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. | Q45866464 | ||
| Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons. | Q45867838 | ||
| A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease | Q45883058 | ||
| Avidin fusion protein-expressing lentiviral vector for targeted drug delivery. | Q46023757 | ||
| Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration | Q46463567 | ||
| Selective loss of central cholinergic neurons in Alzheimer's disease | Q48342983 | ||
| Cholinergic excitation of septohippocampal GABA but not cholinergic neurons: implications for learning and memory. | Q51402433 | ||
| Muscarinic tone sustains impulse flow in the septohippocampal GABA but not cholinergic pathway: implications for learning and memory. | Q52541349 | ||
| p75NGFR and cholinergic neurons in the developing forebrain: a re-examination | Q61204161 | ||
| Receptor binding activities of biotinylated derivatives of beta-nerve growth factor | Q70119055 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 859-870 | |
| P577 | publication date | 2016-05-24 | |
| P1433 | published in | Neurotherapeutics | Q15716631 |
| P1476 | title | Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain | |
| P478 | volume | 13 |
| Q50089571 | Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy | cites work | P2860 |
Search more.